Table 5 Studies included for the meta-analysis
First Author | Year | Region | MMTV-LV Prevalence | Mouse species | Reference |
|---|---|---|---|---|---|
Wang FL | 2020 | China (South) | 2/35 (5.71%) | M.c (1) | – |
Reza MA | 2015 | Iran | 12/100 (12.00%) | M.c (1) | [55] |
San TH | 2017 | Myanmar | 1/58 (1.72%) | M.c (1) | [47] |
Naushad W | 2017 | Pakistan | 83/250 (33.20%) | M.c (1) | [22] |
Ford CE | 2004 | Vietnam | 1/161 (0.62%) | M.c (1) | [56] |
Naushad W | 2014 | Pakistan | 16/80 (20.00%) | M.c (1) | [20] |
Shariatpanahi S | 2017 | Iran | 19/59 (32.20%) | M.c (1) | [57] |
Luo T | 2006 | China | 22/131 (16.79%) | M.c/M.m (1.5) | [46] |
Wang FL | 2020 | China (Nouth) | 19/84 (22.62%) | M.m (2) | – |
Nartey T | 2017 | Australia | 9/25 (36.002%) | M.d (3) | [58] |
Wang Y | 2001 | America | 188/495 (37.98%) | M.d (3) | [31] |
Nazar AMA | 2014 | Iraqi | 22/38 (57.89%) | M.d (3) | [59] |
Lawson JS | 2006 | Australia | 21/59 (35.59%) | M.d (3) | [40] |
Melana SM | 2002 | Argentine | 23/74 (31.08%) | M.d (3) | [33] |
Lawson JS | 2018 | Australia | 12/45 (26.67%) | M.d (3) | [21] |
Lawson JS | 2004 | Australia | 20/42 (47.62%) | M.d (3) | [38] |
Wang Y | 2003 | America | 196/513 (38.21%) | M.d (3) | [35] |
Ford CE | 2003 | Australia | 19/45 (42.22%) | M.d (3) | [34] |
Zapata-Benavides P | 2007 | Mexico | 5/119 (4.20%) | M.d (3) | [42] |
Lawson JS | 2010 | Australia | 33/74 (44.59%) | M.d (3) | [44] |
Mok MT | 2008 | Australia | 28/50 (56.00%) | M.d (3) | [19] |
Glenn WK | 2012 | Australia | 39/50 (78.00%) | M.d (3) | [24] |
Levine PH | 2004 | Tunisia | 28/38 (73.68%) | M.d (3) | [39] |
Melana SM | 2001 | Argentine | 32/106 (30.19%) | M.d (3) | [16] |
Etkind PR | 2004 | America | 6/12 (50.00%) | M.d (3) | [36] |
Faedo M | 2004 | Australia | 50/128 (39.06%) | M.d (3) | [37] |
Ford CE | 2004 | Australia | 45/144 (31.25%) | M.d (3) | [17] |
Mazzanti CM | 2011 | Italy | 47/69 (68.12%) | M.d (3) | [25] |
Pogo BG | 1999 | Italy | 26/69 (37.68%) | M.d (3) | [29] |
Wang Y | 1995 | America | 181/465 (38.92%) | M.d (3) | [28] |
Etkind P | 2000 | America | 27/73 (36.99%) | M.d (3) | [30] |
Al Dossary R | 2018 | Saudi Arabia | 6/101 (5.94%) | M.d (3) | [23] |
Naccarato AG | 2019 | Italy | 17/56 (30.36%) | M.d (3) | [60] |
Zammarchi F | 2006 | Italy | 15/45 (33.33%) | M.d (3) | [41] |
Hachana M | 2008 | Tunisia | 17/122 (13.93%) | M.d (3) | [43] |